Finally, several recent studies have demonstrated that the receptor for advance glycation end products (RAGE) signaling from both melanoma and non-melanoma cells (fibroblasts, immune cells, endothelial cells) in the tumor microenvironment represents an important element in the process of melanoma tumor growth. This evidence concerns the gene AGER and neoplasm.